These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18779754)

  • 1. Inflammation, coronary artery disease, and hormones.
    Lobo RA
    Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
    Koh KK; Bui MN; Mincemoyer R; Cannon RO
    Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
    Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
    Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
    [No Abstract]   [Full Text] [Related]  

  • 6. The time has come to stop letting the HERS tale wag the dogma.
    Mendelsohn ME; Karas RH
    Circulation; 2001 Nov; 104(19):2256-9. PubMed ID: 11696459
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
    Lamon-Fava S; Posfai B; Schaefer EJ
    Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
    [No Abstract]   [Full Text] [Related]  

  • 8. Current views of hormone therapy for the management and treatment of postmenopausal women.
    Stanczyk FZ; Bhavnani BR
    J Steroid Biochem Mol Biol; 2014 Jul; 142():1-2. PubMed ID: 24463311
    [No Abstract]   [Full Text] [Related]  

  • 9. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
    Simpkins JW; Singh M
    J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
    [No Abstract]   [Full Text] [Related]  

  • 10. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
    Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
    J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on 'Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study'.
    Weiping L; Chenxing L; Enfeng Z
    J Obstet Gynaecol Res; 2012 Mar; 38(3):611-2. PubMed ID: 22353571
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy.
    Med Lett Drugs Ther; 2002 Sep; 44(1138):78. PubMed ID: 12238487
    [No Abstract]   [Full Text] [Related]  

  • 13. The antiinflammatory properties of medroxyprogesterone acetate.
    Rachoń D
    Circulation; 2002 Nov; 106(22):e185; author reply e185. PubMed ID: 12451020
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women.
    Yasui T; Saijo A; Uemura H; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    J Reprod Immunol; 2009 Jul; 81(1):97-102. PubMed ID: 19501916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the progestogen added to the estrogen in hormone therapy.
    Lauritzen C
    Climacteric; 2005 Dec; 8(4):398-400. PubMed ID: 16390775
    [No Abstract]   [Full Text] [Related]  

  • 16. Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
    Naftolin F; King J; Morrison JH
    Gynecol Endocrinol; 2010 Jun; 26(6):391-2. PubMed ID: 20175707
    [No Abstract]   [Full Text] [Related]  

  • 17. Summaries for patients. Postmenopausal hormone therapy and blood sugar.
    Ann Intern Med; 2003 Jan; 138(1):I10. PubMed ID: 12513063
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris.
    Chou ET; Schulman SP; Thiemann DR; Sohn RH; Bellantoni MF; Rade JJ
    Am J Cardiol; 2003 May; 91(10):1240-2. PubMed ID: 12745110
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.